Comparison of triglycerides and phospholipids as supplemental sources of dietary long-chain polyunsaturated fatty acids in piglets.
Addition of arachidonic acid (AA) and docosahexaenoic acid (DHA) to infant formula promotes visual and neural development. This study was designed to determine whether the source of dietary long-chain polyunsaturated fatty acids (LCPUFA) affected overall animal health and safety. Piglets consumed ad libitum from 1 to 16 d of age a skim milk-based formula with different fat sources added to provide 50% of the metabolizable energy. Treatment groups were as follows: control (CNTL; no added LCPUFA), egg phospholipid (PL), algal/fungal triglyceride (TG) oils, TG plus PL (soy lecithin source) added to match phospholipid treatment (TG + PL) and essential fatty acid deficient (EFAD). Formulas with LCPUFA provided 0.6 and 0.3 g/100 g total fatty acids as AA and DHA, respectively. CNTL piglets had 40% longer ileal villi than PL piglets (P < 0.03), but the TG group was not different from the CNTL group. Gross liver histology did not differ among any of the formula-fed groups (P > 0.1). Apparent dry matter digestibility was 10% greater in CNTL, TG and TG + PL groups compared with PL piglets (P < 0.002). No differences in alanine aminotransferase were detected among treatments, but aspartate aminotransferase was elevated (P < 0.03) in PL piglets compared with TG + PL piglets. Total plasma AA concentration was greater in the TG group compared with CNTL piglets (P < 0.05). Total plasma DHA concentrations were greater in TG piglets compared with PL (P < 0.06) or CNTL (P < 0.02) piglets. These data demonstrate that the algal/fungal TG sources of DHA and AA may be a more appropriate supplement for infant formulas than the egg PL source based on piglet plasma fatty acid profiles and apparent dry matter digestibilities.
D000410:Alanine Transaminase / Q000378:metabolism; D000821:Animal Feed; D000818:Animals; D000831:Animals, Newborn; D016718:Arachidonic Acid / Q000097:blood; D001219:Aspartate Aminotransferases / Q000378:metabolism; D004042:Dietary Fats, Unsaturated / Q000008:administration & dosage; D004063:Digestion; D004281:Docosahexaenoic Acids / Q000097:blood; D005231:Fatty Acids, Unsaturated / Q000008:administration & dosage* / Q000378:metabolism; D006801:Humans; D007082:Ileum / Q000473:pathology; D007225:Infant Food / Q000032:analysis / Q000592:standards*; D007231:Infant, Newborn; D010743:Phospholipids / Q000008:administration & dosage* / Q000378:metabolism; D011897:Random Allocation; D013552:Swine; D014280:Triglycerides / Q000008:administration & dosage* / Q000378:metabolism; D014792:Visual Acuity / Q000187:drug effects / Q000502:physiology
D004042:Dietary Fats, Unsaturated; D005231:Fatty Acids, Unsaturated; D010743:Phospholipids; D014280:Triglycerides; D004281:Docosahexaenoic Acids; D016718:Arachidonic Acid; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase